RecruitingPhase 2NCT07533006
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Studying Alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eli Lilly and Company
- Principal Investigator
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company
- Intervention
- LY4005130(drug)
- Enrollment
- 60 target
- Eligibility
- 18-50 years · All sexes
- Timeline
- 2026 – 2027
Study locations (29)
- Center For Dermatology Clinical Research, Inc., Fremont, California, United States
- Northridge Clinical Trials, Northridge, California, United States
- Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita, California, United States
- Health Clinical Research, LLC, Miami, Florida, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Revival Research Institute, LLC, Troy, Michigan, United States
- Stracskin, Portsmouth, New Hampshire, United States
- Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio, Texas, United States
- Jordan Valley Dermatology & Research Center, South Jordan, Utah, United States
- Kelowna Health and Memory Centre, Kelowna, Canada
- Ryan Clinical Research Inc., Newmarket, Canada
- Dar Clinical Research - Ottawa - Hunt Club Road, Ottawa, Canada
- SIMa Recherche, Verdun, Canada
- Beijing Friendship Hospital Affiliate of Capital University, Beijing, China
- Huashan Hospital, Fudan University, Shanghai, China
- +14 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07533006 on ClinicalTrials.govOther trials for Alopecia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07435012Androgenic Alopecia TH07 Clinical TrialTriple Hair Inc
- ENROLLING BY INVITATIONNCT07499713Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia AreataIstanbul Training and Research Hospital
- RECRUITINGNANCT07422376Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands RegionCharles Mays
- RECRUITINGNCT07226531Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USPfizer
- RECRUITINGNANCT07563036JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilKasr El Aini Hospital
- RECRUITINGPHASE2NCT07370519Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaShenzhen People's Hospital
- ACTIVE NOT RECRUITINGNANCT07520019Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair Strength in Adults With Self-Perceived Thinning HairNutra Harmony LLC
- RECRUITINGPHASE1, PHASE2NCT07429253Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia PatientsPT. Prodia Stem Cell Indonesia